In conclusion, our findings demonstrated that LINC00202 functioned as an oncogene to regulate RB cell proliferation, apoptosis, and glycolysis by the axis of miR-204-5p/HMGCR (Figure 7f), which might be targeted for therapeutic benefits of RB. The gene discussed is HMGCR; the disease is retinoblastoma.